MX9703101A - Proteina cinasa novedosa (npk-110). - Google Patents

Proteina cinasa novedosa (npk-110).

Info

Publication number
MX9703101A
MX9703101A MX9703101A MX9703101A MX9703101A MX 9703101 A MX9703101 A MX 9703101A MX 9703101 A MX9703101 A MX 9703101A MX 9703101 A MX9703101 A MX 9703101A MX 9703101 A MX9703101 A MX 9703101A
Authority
MX
Mexico
Prior art keywords
protein kinase
npk
alzheimer
maps
cancer
Prior art date
Application number
MX9703101A
Other languages
English (en)
Other versions
MXPA97003101A (es
Inventor
Eckhard Mandelkow
Eva Maria Mandelkow
Jacek Biernat
Gerard Drewes
Original Assignee
Max Planck Gesellschaft
Senschaften E V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft, Senschaften E V filed Critical Max Planck Gesellschaft
Publication of MX9703101A publication Critical patent/MX9703101A/es
Publication of MXPA97003101A publication Critical patent/MXPA97003101A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a una secuencia de ADN que codifica una proteína cinasa neuronal (NPK) novedosa que fosforera proteínas tautoméricas así como otras proteínas asociadas de microtubulo (MARs) en posiciones cruciales para la union a Teorina y epítopes que comprenden dichos residuos fosforilados por dichos NPK o tales MAPs, a anticuerpos que se unen específicamente a dicha proteína cinasa, composiciones farmacéuticas que comprenden inhibidores para dicha proteína cinasa, en particular, para el tratamiento de enfermedad de Alzheimer y cáncer, a equipos de diagnostico y a métodos de diagnostico in vitro para la deteccion de enfermedad de Alzheimer y cáncer.
MXPA/A/1997/003101A 1994-10-28 1997-04-28 Proteina cinasa novedosa (npk-110) MXPA97003101A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94117122.5 1994-10-28
EP94117122 1994-10-28

Publications (2)

Publication Number Publication Date
MX9703101A true MX9703101A (es) 1998-07-31
MXPA97003101A MXPA97003101A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
DE69535901D1 (de) 2009-01-29
AU3870295A (en) 1996-05-23
US6579691B1 (en) 2003-06-17
KR100275591B1 (ko) 2001-02-01
NZ295371A (en) 1998-11-25
WO1996013592A2 (en) 1996-05-09
JPH10508199A (ja) 1998-08-18
HUT77081A (hu) 1998-03-02
CA2203910A1 (en) 1996-05-09
AU714636B2 (en) 2000-01-06
US20030104516A1 (en) 2003-06-05
EP0791067B1 (en) 2008-12-17
ATE417930T1 (de) 2009-01-15
US20040038361A1 (en) 2004-02-26
WO1996013592A3 (en) 1996-08-01
EP0791067A2 (en) 1997-08-27
NO971966L (no) 1997-06-19
US7485712B2 (en) 2009-02-03
CN1168699A (zh) 1997-12-24
NO971966D0 (no) 1997-04-28

Similar Documents

Publication Publication Date Title
EP0911390A3 (en) Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease
WO1996013592A3 (en) Protein kinase npk-110
AU2001294541A1 (en) Mammalian genes; related reagents and methods
EP1308461A3 (en) Antibodies to beta-amyloids or their derivatives and use thereof
EP0987275A3 (en) Molecules that home to a selected organ or tissue in vivo and methods of identifying same
WO2005000193A3 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
NZ270659A (en) Mammalian protein which binds to a gst-fkbp-rapamycin complex, dna therefor and diagnostic compositions
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
DE69605934T2 (de) Cyclin-abhängige kinase bindende verbindungen
MXPA02008239A (es) Gen humano de la esquizofrenia.
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
DK0862653T3 (da) Nukleinsyremolekyler, som er i stand til at skelne mellem PrPc- og PrPSc-isoformerne af prionproteiner og fremgangsmåder til fremstilling deraf
DE69634438D1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR FIXING TAU AND MAP2c PROTEINS
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
HUP0302566A2 (hu) Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására
DE69632457D1 (de) Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung
WO2001064876A3 (en) Human schizophrenia gene
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
EP0780472A3 (en) Stress proteins
WO2002072626A3 (de) Neue form des phgpx-proteins als diagnostischer marker bei männlicher infertilität
WO2001002429A3 (en) Angiopoietin-6 and uses thereof
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods